Individual Response to Different Volumes of Resistance Training
5 november 2015 uppdaterad av: Inland Norway University of Applied Sciences
Determinants of Intra-individual Variation in Adaptability to Resistance Training of Different Volumes
The literature is not clear as to which training volume to employ during initial phases of resistance training programs to ensure optimal muscular adaptations. The purpose of this study is therefore to compare effects of strength training with low versus moderate volume on muscular function and hypertrophy in previously untrained, healthy individuals. Furthermore, the investigators will relate individual variation in responses to proxy markers of individual training state, such as baseline muscular function and muscle fiber type.
The study will include 25 women and 25 men and will consist of a 12-week resistance training protocol. Each study participant will act as their own control, performing both the low- (1-set) and the moderate-volume (3-sets) protocol, allocated to either the dominant or non-dominant leg, in a stratified and randomized fashion.
Primary outcome measures are thigh muscle cross section area and unilateral knee extension strength. Additionally, muscle fiber type composition will be evaluated as well as additional parameters of muscular function.
The primary hypothesis is that low-volume protocols will be beneficial for individuals with glycolytic muscle phenotypes, whereas the opposite will be true for individuals with more aerobic phenotypes.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
42
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Lillehammer, Norge
- Lillehammer University College
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 40 år (Vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Healthy
- Non-smoking
- Able to tolerate resistance exercise training
Exclusion Criteria:
- Presence or history of cardiovascular, metabolic, endocrine or neuromuscular disease
- Diagnosed mental health disorder
- Intolerance to local anesthetic
- No experience with exercise training
- Performing regular resistance training (more than 1 session per week during last 12 months)
- Impaired strength/ neuromuscular function due to previous injury
- Recurrent pain in lower back, knee or shoulders
- Taking prescribed medication that may affect outcome of training intervention
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Arm label 1-Set, 3-Set
12-week progressive strength training protocol of different volumes
|
Every study participant will complete 12 weeks of progressive strength training with one leg performing 1-set per exercise per session and the contralateral leg performing 3-sets per exercise per session.
Allocation of dominant/non-dominant leg to either 1- or 3-set protocol will be done in a stratified, randomized fashion (stratified with regard to sex and baseline strength).
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Thigh muscle cross-sectional area
Tidsram: Week 0 (baseline) and 12 (post training intervention)
|
Changes in muscle cross sectional area of each thigh from baseline to post intervention, assessed by MRI.
|
Week 0 (baseline) and 12 (post training intervention)
|
|
Unilateral knee-extension isometric strength
Tidsram: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
Time course changes in maximum knee extensor, isometric strength evaluated at 120° knee angle (180° fully extended).
|
Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Muscle strength
Tidsram: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
Time course changes in maximum isoinertial strength defined by one-repetition maximum in leg press, knee extension, knee flexion, and bench press.
|
Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
|
Knee extensors and flexors force-velocity relationship
Tidsram: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
Time course changes in torque measured during maximal voluntary isokinetic contraction at 60°, 120° and 240° ∙ sec-1.
|
Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
|
|
Blood hormonal profiles
Tidsram: Week 0 (baseline), 2 and 12 (post training intervention)
|
Resting (week 0, 2 and 12) and acutely exercise-induced (week 2) hormonal profiles (testosterone, insulin-like growth factor 1, growth hormone and cortisol) determined in serum from venous blood samples.
|
Week 0 (baseline), 2 and 12 (post training intervention)
|
|
Muscle fiber cross-sectional area
Tidsram: Week 0 (baseline), 2 and 12 (post training intervention)
|
Changes in muscle fiber cross-sectional area assessed by immunohistochemistry from muscle biopsy.
Determined from muscle biopsy samples (Vastus lateralis).
|
Week 0 (baseline), 2 and 12 (post training intervention)
|
|
Protein expression
Tidsram: Week 0 (baseline), 2 and 12 (post training intervention)
|
Changes in relative abundance of contractile protein isoforms (myosin heavy chain).
Modification of proteins related to muscle hypertrophy in relation to an acute exercise session (assessed during week 2 of the intervention).
Determined from muscle biopsy samples (Vastus lateralis).
|
Week 0 (baseline), 2 and 12 (post training intervention)
|
|
Gene expression
Tidsram: Week 0 (baseline), 2 and 12 (post training intervention)
|
Changes in gene expression related to skeletal muscle hypertrophy and structural phenotype measured in steady state conditions (biopsy sampled in resting conditions, week 0, 2 and 12) and in relation to acute exercise (biopsy sampled 1-h after strength exercise, week 2).
Determined from muscle biopsy samples (Vastus lateralis).
|
Week 0 (baseline), 2 and 12 (post training intervention)
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Body composition changes
Tidsram: Week 0 (baseline) and 12 (post training intervention)
|
Changes in body compositions (lean mass and fat mass) from prior intervention to after intervention assessed by dual x-ray absorptiometry scan.
|
Week 0 (baseline) and 12 (post training intervention)
|
|
Habitual physical activity
Tidsram: Week 0
|
Self-reported prior habitual physical activity assessed by questionnaire and interview before training intervention
|
Week 0
|
|
Daily nutrient intake
Tidsram: Week 6
|
Daily nutrient intake assessed by a 4-day food intake registration.
|
Week 6
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Stian Ellefsen, PhD, Inland Norway University of Applied Sciences
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 augusti 2014
Primärt slutförande (Faktisk)
1 april 2015
Avslutad studie (Faktisk)
1 april 2015
Studieregistreringsdatum
Först inskickad
27 juni 2014
Först inskickad som uppfyllde QC-kriterierna
30 juni 2014
Första postat (Uppskatta)
1 juli 2014
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
6 november 2015
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
5 november 2015
Senast verifierad
1 november 2015
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- Trainsome 2014#002
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Friska
-
University of MiamiJames and Esther King Biomedical Research ProgramAvslutadHealthy Lifetime Icke-rökareFörenta staterna
-
University of LeicesterNational Institute for Health Research, United KingdomAvslutadPatienter med hjärtsvikt och konserverad ejektionsfraktion - HFpEF | Patienter med hjärtsvikt med reducerad ejektionsfraktion - HFrEF | Healthy Controls Group - ålders- och könsmatchad
-
University Hospital, GrenobleUniversity Hospital, Clermont-Ferrand; Grenoble Institut des NeurosciencesAvslutadParkinsons sjukdom | Healthy Controls Group - ålders- och könsmatchadFrankrike